2 -Adrenoceptor agonists stimulate high-affinity GTPase activity in a receptor subtype-selective manner

By Jansson C.C.   Pohjanoksa K.   Lang J.   Wurster S.   Savola J.-M.   Scheinin M.  

European Journal of Pharmacology, Vol. 374, Iss. 1, 1999-06 ,pp. : 137-146

Elsevier

Access to resources Recommend Favorite

Nicotinic receptor partial agonists as novel compounds for the treatment of smoking cessation

By Tutka Piotr  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 10, 2008-10 ,pp. : 1473-1485

Informa Healthcare

Access to resources Recommend Favorite

Structural aspects of high affinity ligands for the 4 2 neuronal nicotinic receptor

By Dart M.J.   Wasicak J.T.   Ryther K.B.   Schrimpf M.R.   Kim K.H.   Anderson D.J.   Sullivan J.P.   Meyer M.D.  

Pharmaceutica Acta Helvetiae, Vol. 74, Iss. 2, 2000-03 ,pp. : 115-123

Elsevier

Access to resources Recommend Favorite

Novel oxytocin receptor agonists and antagonists: a patent review (2002 – 2013)

By Yang Yang   Li Hao   Ward Richard   Gao Linghuan   Wei Ji-Fu   Xu Tian-Rui  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 1, 2014-01 ,pp. : 29-46

Informa Healthcare

Access to resources Recommend Favorite

Neuronal nicotinic acetylcholine receptor agonists

By Toma Lucio   Barlocco Daniela   Gelain Arianna  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 7, 2004-07 ,pp. : 1029-1040

Informa Healthcare

Access to resources Recommend Favorite